VLST Corp. and Novo Nordisk, Inc. (NVO) Announce Collaboration Agreement to Develop Therapeutics for Autoimmune and Inflammatory Disorders
12/17/2008 6:26:35 AM
More...
|
VLST Corp. Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer
7/2/2008 9:29:05 AM
More...
|
VLST Corp. Announces Board and Executive Management Appointments
2/13/2008 11:55:33 AM
More...
|
VLST Corp. Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design
9/17/2007 8:16:58 AM
More...
|
Fifty-Seven Life Science Companies Selected To Present At Invest Northwest(C) 2007
1/5/2007 2:52:16 PM
More...
|
VLST Corp. Raises $55 Million Series B Financing
6/16/2006 10:30:35 AM
More...
|
VLST Corp. Names Julie M. Eastland As Chief Financial Officer
3/6/2006 1:16:42 PM
More...
|
VLST Corp. Names Julie M. Eastland As Chief Financial Officer
3/3/2006 1:09:42 PM
More...
|
VLST Corp. And Accelerator Corporation Name Martin A. Simonetti President And Chief Executive Officer
1/6/2006 10:23:48 AM
More...
|
Accelerator Corporation Funds Two Emerging Biotech Companies; Seattle-based VieVax Corp. And VLST Corp. First Start-Ups To Join Accelerator
10/19/2005 5:11:25 PM
More...
|